Cholangitis diagnostic study of choice

Jump to navigation Jump to search

Cholangitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholangitis diagnostic study of choice On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholangitis diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholangitis diagnostic study of choice

CDC on Cholangitis diagnostic study of choice

Cholangitis diagnostic study of choice in the news

Blogs on Cholangitis diagnostic study of choice

Directions to Hospitals Treating Cholangitis

Risk calculators and risk factors for Cholangitis diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Magnetic resonance cholangiopancreatography (MRCP) is the diagnostic study of choice for identifying lesions of the biliary tree with sensitivity comparable to that of endoscopic retrograde cholangiopancreaticography (ERCP).

Diagnostic Study of Choice

  • Magnetic resonance cholangiopancreatography (MRCP) is the diagnostic study of choice for identifying lesions of the biliary tree with sensitivity comparable to that of endoscopic retrograde cholangiopancreaticography ERCP[1].
  • MRCP is non-invasive and does not require contrast medium.
  • Biliary stones < 5mm may be missed on MRCP[2][3].
  • MRCP can identify if the lesion in the biliary tree is situated high or low.
  • This identification of the location of the lesion may aid in choosing the appropriate intervention (for example, PTC for high lesions and ERCP for lesions situated lower down the biliary tree).

References

  1. Zhong L, Xiao SD, Stoker J, Nj Tytgat G (2004). "Magnetic resonance cholangiopancreatography". Chin J Dig Dis. 5 (4): 139–48. doi:10.1111/j.1443-9573.2004.00174.x. PMID 15612882.
  2. Miller JC, Harisinghani M, Richter JM, Thrall JH, Lee SI (February 2007). "Magnetic resonance cholangiopancreatography". J Am Coll Radiol. 4 (2): 133–6. doi:10.1016/j.jacr.2006.10.002. PMID 17412247.
  3. Sahni VA, Mortele KJ (September 2008). "Magnetic resonance cholangiopancreatography: current use and future applications". Clin Gastroenterol Hepatol. 6 (9): 967–77. doi:10.1016/j.cgh.2008.05.017. PMID 18774532.

Template:WH Template:WS